Berit Müller

Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer

Carsten Denkert, Sibylle Loibl, Aurelia Noske et al. · Journal of Clinical Oncology · 2009 · 1.8K citations

Breast Oncology, Immunology, Pathology +17

Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression

Mika Hilvo, Carsten Denkert, Laura Lehtinen et al. · Cancer Research · 2011 · 529 citations

Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer

Gϋnter von Minckwitz, Holger Eidtmann, Mahdi Rezai et al. · New England Journal of Medicine · 2012 · 528 citations

Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial

Carsten Denkert, Sibylle Loibl, Berit Müller et al. · Annals of Oncology · 2013 · 244 citations · Full text

Breast Oncology, Medicine, Ki67 Levels +8

Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer - overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression

Berit Müller, Lisa Jana, Atsuko Kasajima et al. · BMC Cancer · 2013 · 242 citations · Full text